Suppr超能文献

开始接受前列腺癌雄激素剥夺治疗的男性及开始接受乳腺癌抗雌激素治疗的女性的骨骼健康管理。

Bone Health Management in Men Commencing Androgen Deprivation Therapy for Prostate Cancer and Women Commencing Anti-Oestrogen Therapy for Breast Cancer.

作者信息

Liang Ian, Brennan Sarah, Girgis Christian, Hayden Amy, Moujaber Tania, Turner Sandra, Vasista Anuradha, Grossmann Mathis, Wong Peter K K

机构信息

Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia.

Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.

出版信息

Cancer Med. 2025 May;14(9):e70873. doi: 10.1002/cam4.70873.

Abstract

BACKGROUND

Survival of patients with prostate and breast cancer, the commonest cancer in men and women, respectively, has markedly improved with advances in early diagnosis, treatment and multi-disciplinary care by the oncology and surgical community. However, the use of increasingly potent endocrine therapies may cause bone loss, resulting in secondary osteoporosis.

REVIEW

This review summarises the current management of cancer treatment-induced bone loss in this group of patients at high risk of osteoporotic fractures with their attendant morbidity and mortality.

CONCLUSION

Bone health is an increasingly important part of cancer survivorship. Radiation and medical oncologists, urologists, bone health experts, general practitioners, healthcare professional bodies and bone health and cancer consumer organisations should increase awareness of the potential adverse effect of endocrine therapy on bone health. While this should never delay cancer treatment, bone health should be part of routine care for men and women receiving endocrine therapy for prostate and breast cancer.

摘要

背景

前列腺癌和乳腺癌分别是男性和女性中最常见的癌症,随着肿瘤学和外科领域在早期诊断、治疗及多学科护理方面取得的进展,这两类癌症患者的生存率有了显著提高。然而,使用日益强效的内分泌疗法可能会导致骨质流失,进而引发继发性骨质疏松症。

综述

本综述总结了当前针对这组有骨质疏松性骨折高风险及其相关发病率和死亡率的患者,对癌症治疗引起的骨质流失的管理方法。

结论

骨骼健康在癌症幸存者护理中变得越来越重要。放射肿瘤学家、医学肿瘤学家、泌尿科医生、骨骼健康专家、全科医生、医疗保健专业机构以及骨骼健康和癌症患者组织应提高对内分泌疗法对骨骼健康潜在不良影响的认识。虽然这绝不应延误癌症治疗,但骨骼健康应成为接受前列腺癌和乳腺癌内分泌治疗的男性和女性常规护理的一部分。

相似文献

2
Bone health during endocrine therapy for cancer.
Lancet Diabetes Endocrinol. 2018 Nov;6(11):901-910. doi: 10.1016/S2213-8587(18)30047-0. Epub 2018 Mar 20.
3
Management of bone loss due to endocrine therapy during cancer treatment.
Osteoporos Int. 2023 Apr;34(4):671-680. doi: 10.1007/s00198-023-06672-3. Epub 2023 Jan 19.
4
[Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer].
Wien Med Wochenschr. 2012 Sep;162(17-18):380-5. doi: 10.1007/s10354-012-0106-z. Epub 2012 Aug 9.
5
Background to and management of treatment-related bone loss in prostate cancer.
Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
7
[Treatment effect of breast cancer and prostate cancer on bone].
Med Clin (Barc). 2013 Feb 16;140(4):164-8. doi: 10.1016/j.medcli.2012.05.025. Epub 2012 Jul 28.
8
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11.
9
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Ann Intern Med. 2017 Sep 5;167(5):341-350. doi: 10.7326/M16-2577. Epub 2017 Aug 8.
10

本文引用的文献

4
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.
NEJM Evid. 2022 Dec;1(12):EVIDoa2200162. doi: 10.1056/EVIDoa2200162. Epub 2022 Nov 18.
6
Hormone receptors in breast cancer: An update on the uncommon subtypes.
Pathol Res Pract. 2023 Oct;250:154791. doi: 10.1016/j.prp.2023.154791. Epub 2023 Sep 3.
7
Multi-Targeting DKK1 and LRP6 Prevents Bone Loss and Improves Fracture Resistance in Multiple Myeloma.
J Bone Miner Res. 2023 Jun;38(6):814-828. doi: 10.1002/jbmr.4809. Epub 2023 May 25.
8
Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study.
J Bone Miner Res. 2023 May;38(5):650-658. doi: 10.1002/jbmr.4804. Epub 2023 Apr 9.
10
Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study.
J Bone Miner Res. 2023 May;38(5):659-664. doi: 10.1002/jbmr.4793. Epub 2023 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验